Evidence map›Paper›PMID 31431921›Full record

ReviewJournal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)2019

Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View.

Alexandra Lazăr, Anca Meda Georgescu, Alexander Vitin, Leonard Azamfirei

Abstract readReview
In one paragraph

Review in Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Metabolic footprint of sepsis and septic shock: A narrative review.World journal of critical care medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. The Human Microbiome in Intensive Care - A Journey Forward?Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2023
    Article
  7. Is Carboxyhaemoglobin an Effective Bedside Prognostic Tool for Sepsis and Septic Shock Patients?Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2023
    Article
  8. Fluid Therapy from Friend to Foe.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2023
    Article
  9. Observational
  10. Article
  11. Personalized Physiological Medicine as the Future of Intensive Care Medicine.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2022
    Article
  12. Article
  13. Genetic Susceptibility to Acute Kidney Injury.Journal of clinical medicine · 2021
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra LazărDepartment of Anesthesiology and Intensive Care, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania.
Anca Meda GeorgescuDepartment of Infectious Diseases, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania.
Alexander VitinDepartment of Anesthesiology & Pain, Medicine University of Washington Medical Center, Seattle WA, USA.
Leonard AzamfireiDepartment of Anesthesiology and Intensive Care, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, a new form of medicine has become increasingly significant, namely, personalised medicine (PM). PM is a form of care in which treatment is tailored for an individual patient. PM is about using multiple data sets to create a digital human mapping. A person's biological traits are determined by the interactions of hundreds of genes and gene networks, as well as external factors such as diet and exercise. Combining and then investigating these multiple databases with powerful statistical tools, allows a new understanding of how genetic intricacy drives health and disease and so leads to a closer personalised medical approach that targets each individual's unique genetic make-up. Sepsis is a systemic inflammatory response to infection, ranging from systemic inflammatory response syndrome (SIRS) to septic shock and multiple organ dysfunction syndromes (MODS). Sepsis is the most common cause of death in intensive care patients. Treatments in an ICU may need to be adapted to the continuous and rapid changes of the disease, making it challenging to identify a single target. PM is thus seen as the future of sepsis treatment in the ICU. The fact that individual patients respond differently to treatment should be regarded as a starting point in the approach to providing treatment. The disease itself comes secondary to this concept.

Indexed as

genomeintensive caremultiple datasetsprecision medicinesepsis

Identifiers

PMID31431921
PMCPMC6698074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.